Hepatitis B virus pregenomic RNA in hepatocellular carcinoma: A nosological and prognostic determinant
B Halgand,
C Desterke,
L Riviere,
G Fallot,
M Sebagh,
Julien CALDERARO,
P Bioulac-Sage,
C Neuveut,
MA Buendia,
D Samuel,
Cyrille FERAY,
Hepatology. 01/01/2018;67(1) : 86-96 10.1002/hep.29463
Living or Brain-dead Donor Liver Transplantation for Hepatocellular Carcinoma: A Multicenter, Western, Intent-to-treat Cohort Study
D Azoulay,
E Audureau,
P Bhangui,
J Belghiti,
O Boillot,
P Andreani,
D Castaing,
D Cherqui,
S Irtan,
Y Calmus,
O Chazouilleres,
O Soubrane,
Alain LUCIANI,
Cyrille FERAY,
Ann Surg. 01/12/2017;266(6) : 1035-1044 10.1097/SLA.0000000000001986
Salvage liver transplantation or repeat hepatectomy for recurrent hepatocellular carcinoma: An intent-to-treat analysis
C Lim,
H Shinkawa,
K Hasegawa,
P Bhangui,
C Salloum,
C Gomez Gavara,
E Lahat,
K Omichi,
J Arita,
Y Sakamoto,
P Compagnon,
Cyrille FERAY,
N Kokudo,
D Azoulay,
Liver Transpl. 01/12/2017;23(12) : 1553-1563 10.1002/lt.24952.
Impact of time to surgery in the outcome of patients with liver resection for BCLC 0-A stage hepatocellular carcinoma
C Lim,
P Bhangui,
C Salloum,
C Gomez Gavara,
E Lahat,
Alain LUCIANI,
P Compagnon,
Julien CALDERARO,
Cyrille FERAY,
D Azoulay,
J Hepatol. 06/10/2017;pii: S0168-8278(17) : 32331-0 10.1016/j.jhep.2017.09.017